Cost analysis of residual viremia detected by two real-time PCR assays for response-guided (dual or triple) therapy of HCV genotype 1 infection

Cost analysis of residual viremia detected by two real-time PCR assays for response-guided (dual or triple) therapy of HCV genotype 1 infection

Cost analysis of residual viremia detected by two real-time PCR assays for response-guided (dual or triple) therapy of HCV genotype 1 infectionIntroductionThe duration of interferon-based dual and triple therapies for HCV-G1 is determined by assessment of early viral kinetics. We conducted a cost an...

Full description

Bibliographic Details
Main Authors: Alessio Aghemo, Giovanna Lunghi, Roberto Ravasio, Erminio Torresani, Matteo Dionisi, Davide Paolini, Massimo Colombo
Format: Article
Language:English
Published: AboutScience Srl 2016-12-01
Series:Global & Regional Health Technology Assessment
Online Access:http://www.grhta.com/Attach/D0F9279E-40C4-4EC5-8527-4C6A0C662420/87B2300D-95E6-4833-A36D-9900483DE8B4

Internet

http://www.grhta.com/Attach/D0F9279E-40C4-4EC5-8527-4C6A0C662420/87B2300D-95E6-4833-A36D-9900483DE8B4

Similar Items